Axa S.A. Amarin Corp Plcuk Transaction History
Axa S.A.
- $29.5 Billion
- Q1 2025
A detailed history of Axa S.A. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Axa S.A. holds 61,937 shares of AMRN stock, worth $932,151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,937
Previous 989,359
93.74%
Holding current value
$932,151
Previous $474,000
16.88%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMRN
# of Institutions
111Shares Held
64.4MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$374 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$187 Million9.37% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$51.2 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$39.5 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$37.6 Million17.88% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.07B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...